Glucocorticoid therapy: minimizing side effects, J Pediatr, vol.83, pp.163-77, 2007. ,
A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy, Allergy Asthma Clin Immunol, vol.9, p.30, 2013. ,
metabolism and metabolic diseases, Mol Cell Endocrinol, vol.275, pp.43-61, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00531932
Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity, Biochim Biophys Acta, vol.1842, pp.473-81, 2014. ,
Effects of low-dose prednisolone on hepatic and peripheral insulin sensitivity, insulin secretion, and abdominal adiposity in patients with inflammatory rheumatologic disease, Diabetes Care, vol.36, pp.2822-2831, 2013. ,
Endocrine and physiological changes in response to chronic corticosterone: a potential model of the metabolic syndrome in mouse, Endocrinology, vol.151, pp.2117-2144, 2010. ,
Chronic corticosterone treatment during adolescence has significant effects on metabolism and skeletal development in male C57BL6/N mice, Endocrinology, vol.158, pp.2239-54, 2017. ,
A rodent model of rapid-onset diabetes induced by glucocorticoids and high-fat feeding, Dis Model Mech, vol.5, pp.671-80, 2012. ,
Glucocorticoid-induced obesity develops independently of UCP1, Cell Rep, vol.27, pp.1686-98, 2019. ,
Glucocorticoid treatment and endocrine pancreas function: implications for glucose homeostasis, insulin resistance and diabetes, J Endocrinol, vol.223, pp.49-62, 2014. ,
Beta cell adaptation to dexamethasone-induced insulin resistance in rats involves increased glucose responsiveness but not glucose effectiveness, Pancreas, vol.22, pp.148-56, 2001. ,
Glucocorticoid-induced osteoporosis, RMD Open, vol.1, p.14, 2015. ,
Reducing glucocorticoid dosage improves serum osteocalcin in patients with rheumatoid arthritis-results from the TOMORROW study, Osteoporos Int, vol.27, pp.729-764, 2016. ,
Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism, J Clin Invest, vol.122, pp.4172-89, 2012. ,
Endocrine regulation of energy metabolism by the skeleton, Cell, vol.130, pp.456-69, 2007. ,
Adiponectin as a biomarker of the metabolic syndrome, Circ J, vol.68, pp.975-81, 2004. ,
Role of adiponectin and adipocyte fatty acid binding protein in the metabolic syndrome, Diabetes Res Clin Pract, vol.77, pp.17-22, 2007. ,
Adiponectin receptors in human adipose tissue: effects of obesity, weight loss, And Fat Depots Obesity, vol.14, pp.28-35, 2006. ,
Adiponectin receptor 1 regulates bone formation and osteoblast differentiation by GSK-3beta/beta-catenin signaling in mice, Bone, vol.64, pp.147-54, 2014. ,
Adiponectin receptor signalling in the brain, Br J Pharmacol, vol.165, pp.313-340, 2012. ,
Prevention and treatment of systemic glucocorticoid side effects, Int J Dermatol, vol.49, pp.239-287, 2010. ,
A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity, Nature, vol.503, pp.493-502, 2013. ,
Adiporon, an adiponectin receptor agonist acts as an antidepressant and metabolic regulator in a mouse model of depression, Transl Psychiatry, vol.8, p.159, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01868962
Oxytocin reverses ovariectomy-induced osteopenia and body fat gain, Endocrinology, vol.155, pp.1340-52, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-00968717
Enriched environment decreases microglia and brain macrophages inflammatory phenotypes through adiponectin-dependent mechanisms: relevance to depressive-like behavior, Brain Behav Immun, vol.50, pp.275-87, 2015. ,
Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects, Arterioscler Thromb Vasc Biol, vol.28, pp.1654-1663, 2008. ,
, bone and energy metabolism. Bone, vol.82, pp.64-72, 2016.
Quantification of the risk of corticosteroid-induced diabetes mellitus among the elderly, J Gen Intern Med, vol.17, pp.717-737, 2002. ,
Side effects of corticosteroid therapy, J Clin Gastroenterol, vol.33, pp.289-94, 2001. ,
Glucose metabolism abnormalities in cushing syndrome: from molecular basis to clinical management, Endocr Rev, vol.38, pp.189-219, 2017. ,
Hyperinsulinemia caused by dexamethasone treatment is associated with reduced insulin clearance and lower hepatic activity of insulin-degrading enzyme, J Steroid Biochem Mol Biol, vol.155, pp.1-8, 2016. ,
Adipose tissue plasticity: how fat depots respond differently to pathophysiological cues, Diabetologia, vol.59, pp.1075-88, 2016. ,
Adiponectin, leptin, and fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk, Cell Metab, vol.23, pp.770-84, 2016. ,
Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast, Biochem Biophys Res Commun, vol.331, pp.520-526, 2005. ,
Adiponectin regulates bone mass via opposite central and peripheral mechanisms through FoxO1, Cell Metab, vol.17, pp.901-916, 2013. ,